PPT Slide
Patent and Licensing of Factor VIII
Plasma-derived
Cross-licensed 1982, 1989
Gene Patent
Process Patent
X
Blocked by courts in 1995
Protein Purity Patent
1984
1982
$55m+
1993 $105m
Expires 2005
Expires 2007
1982,’89
Genetics Institute
Red Cross AHF-ARC
Behringwerke
Humate
Centeon
Monoclate-P
RPR/Armour Hyate C
Bayer
Koate HP
NYBC/Melville
Factor VIII SD
Genentech
Melville
MelATE
Scripps
Centeon
Helixate
Bayer
Kogenate
Alpha
Profilate OSD
Alpha
Alphanate
Chiron
Novo
Centeon
Bioclate
Baxter
Recombinate
Baxter
Hemofil-M
Gene-derived
Previous slide
Next slide
Back to first slide
View graphic version